SIRT1 and Parkinson disease: Moreover, reduced SIRT1 concentrations were associated with increased disease severity and poorer cognitive function, suggesting that SIRT1 may serve as a potential biomarker for both disease progression and cognitive impairment in Parkinson’s disease (Zhu et al., 2021).